Rein Therapeutics, Inc. (RNTX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.96 | +44.2% |
| 2024 | $-3.51 | -2.6% |
| 2023 | $-3.42 | +43.2% |
| 2022 | $-6.02 | -2.2% |
| 2021 | $-5.89 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.96 | +44.2% |
| 2024 | $-3.51 | -2.6% |
| 2023 | $-3.42 | +43.2% |
| 2022 | $-6.02 | -2.2% |
| 2021 | $-5.89 | — |